Clinical trial
A Pilot Phase II Trial of Temozolomide in Leptomeningeal Metastases
NCT00005812 is registered in ClinicalTrials.gov with Dartmouth-Hitchcock Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pilot Phase II Trial of Temozolomide in Leptomeningeal Metastases
- Lead sponsor
- Dartmouth-Hitchcock Medical Center
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- January 31, 2000
- Completion date
- May 31, 2004
- Enrollment
- 12 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
brain tumors, central nervous system tumors, leptomeningeal metastases